ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic…

Drug Manufacturers - Specialty & Generic

US, Garden City [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Major Shareholders · Proxy Ben. Owners

Shareholders

Major Shareholders · Structure

Breakdown

The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for ProPhase Labs, Inc.

ProPhase Labs, Inc. can't present any analysts estimates at the moment detail analysis.

Intraday

Shares Outstanding

23,874,000

Volume

182,854

Volume on Avg.

263,859

Beneficial Owners Beta

Beneficial owners who control a significant portion of the shares outstanding.

SEC Source

Form 3/4/5

Owner	Shares	Equivalence - $0.60 per share	Last Form/Filing	Last Transaction
10% Holder
Karkus Ted William Internal : CEO & CHAIRMAN	View the form. Palmy doesn't track derivative holdings.
Officers/Directors Below 10%
Latkin Jed Internal : Director	0	$0	03/19/24	0 x $0 = $0
Hirsch Warren Internal : Director	0	$0	07/05/22	0 x $0 = $0
Gleckel Louis Md Internal : Director	98,590	$59,154.00	08/16/19	A 4,727 x $2.38 = $11,250.26
Barr Jason Michael Internal : Director	21,873	$13,123.80	01/03/20	A 2,782 x $2.02 = $5,619.64
Morse Robert A. Jr. Internal : CHIEF FINANCIAL OFFICER	0	$0	01/13/23	0 x $0 = $0
Brady Monica L. Internal : Chief Accounting Officer	0	$0	08/18/20	0 x $0 = $0
White Billy Joe Internal : Chief Financial Officer	0	$0	05/23/22	0 x $0 = $0